Disclosure Regarding non-applicability of Regulation 24a of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aptus Pharma Ltd has filed a disclosure with BSE regarding the non-applicability of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Regulation 24A typically pertains to corporate governance requirements, including obligations related to shareholder meetings or related party transactions. The company has stated that this regulation does not apply to them, likely due to not meeting certain thresholds or criteria. The actual detailed document content was not accessible at the time of analysis as the BSE page returned an error. This type of filing is routine for companies that fall below specified thresholds for corporate governance requirements.
This filing indicates Aptus Pharma Ltd qualifies for an exemption from certain SEBI corporate governance norms, which is typically neutral for shareholders as it relates to regulatory compliance rather than business performance.